Homeβ€ΊSearchβ€ΊTranslational Neurodegeneration

Translational Neurodegeneration

BioMed Central Ltd Β· United Kingdom Β· Est. 1979

ISSN2047-9158eISSN2047-9158
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
156
days submission β†’ published
measured Β· last 20 articles Β· accept 128d
10
weeks to publish Β· journal-reported
Fast Β· vs ~15 wk median
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
4.992
H-Indexi
88
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
2.19
Total Worksi
602
Total Citationsi
33,383
2yr Mean Citednessi
13.55
Open Impact Factor alternative
Retractions
3
Source: Retraction Watch

Aims & Scope

Subject areas: Neurosciences; Cellular and Molecular Neuroscience; Cognitive Neuroscience; Neurology (clinical).

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1979
Annual Volume~ 67 articles / year
StatusActive (last: 2026)
Total Publications602
Publisher OrgBioMed Central
Region🌍 Global South
OA Since2011
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~10 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC0
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
πŸ“¦ Long-term Preservation
British Library; Koninklijke BibliotheekCLOCKSSLOCKSSPorticoPMC

Think.Check.Submit Compliance

10/12 Β· 83%
βœ…
Do you know the journal / publisher?
BioMed Central Ltd
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2047-9158 / 2047-9158
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
βœ…
Long-term digital preservation?
British Library; Koninklijke Bibliotheek, CLOCKSS, LOCKSS, Portico, PMC
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
38
2.7k
2019
45
5.7k
2020
50
2.6k
2021
58
4k
2022
59
2.7k
2023
68
1.9k
2024
73
705
2025
27
15
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Cellular and Molecular NeuroscienceQ1
Cognitive NeuroscienceQ1
Neurology (clinical)Q1

Subject Classification

Web of Science Categories

Neurosciences

Scopus Categories

Neurology (clinical)Cellular and Molecular NeuroscienceCognitive Neuroscience

Research Topics (OpenAlex)

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNeurological disorders and treatmentsAmyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment ResearchGenetic Neurodegenerative DiseasesMitochondrial Function and PathologyNeurogenesis and neuroplasticity mechanismsNeurological diseases and metabolism

Frequently asked questions about Translational Neurodegeneration

Is Translational Neurodegeneration a predatory journal?

PubScope has no integrity flags on record for Translational Neurodegeneration: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Translational Neurodegeneration?

Translational Neurodegeneration is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 13.55.

Is Translational Neurodegeneration indexed in Scopus and Web of Science?

Translational Neurodegeneration is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Translational Neurodegeneration?

Subject areas: Neurosciences; Cellular and Molecular Neuroscience; Cognitive Neuroscience; Neurology (clinical).

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref